Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
22.87
-1.80 (-7.30%)
At close: Jun 26, 2026, 4:00 PM EDT
23.64
+0.77 (3.37%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Faeth Therapeutics Employees
Faeth Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 14 or 93.33% compared to the previous year.
Employees
29
Change (1Y)
14
Growth (1Y)
93.33%
Revenue / Employee
n/a
Profits / Employee
-$6,360,586
Market Cap
589.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| 4D Molecular Therapeutics | 196 |
| CorMedix | 191 |
| Rigel Pharmaceuticals | 174 |
| BridgeBio Oncology Therapeutics | 106 |
| SpyGlass Pharma | 68 |
| AgomAb Therapeutics NV | 62 |
| Bright Minds Biosciences | 26 |
FTH News
- 2 days ago - Faeth Therapeutics initiated with an Outperform at Baird - TheFly
- 5 days ago - Faeth Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 9 days ago - Faeth Therapeutics files automatic mixed securities shelf - TheFly
- 12 days ago - Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer - Business Wire
- 23 days ago - Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - Business Wire
- 7 weeks ago - Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer - Business Wire
- 2 months ago - Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - Business Wire